home / stock / mrns / mrns quote
Last: | $1.41 |
---|---|
Change Percent: | -1.39% |
Open: | $1.46 |
Close: | $1.41 |
High: | $1.53 |
Low: | $1.17 |
Volume: | 4,816,224 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.41 | $1.46 | $1.41 | $1.53 | $1.17 | 4,816,224 | 04-18-2024 |
$1.44 | $1.23 | $1.44 | $1.54 | $1.16 | 10,367,883 | 04-17-2024 |
$1.2 | $1.32 | $1.2 | $1.65 | $1.11 | 22,196,654 | 04-16-2024 |
$1.3 | $1.85 | $1.3 | $1.95 | $1.25 | 35,571,117 | 04-15-2024 |
$7.52 | $7.87 | $7.52 | $7.99 | $7.4 | 623,997 | 04-12-2024 |
$7.92 | $8.17 | $7.92 | $8.26 | $7.9 | 434,207 | 04-11-2024 |
$8.09 | $8.16 | $8.09 | $8.28 | $7.88 | 671,287 | 04-10-2024 |
$8.38 | $8.18 | $8.38 | $8.45 | $8.04 | 634,519 | 04-09-2024 |
$8.2 | $7.85 | $8.2 | $8.26 | $7.4201 | 688,720 | 04-08-2024 |
$7.8 | $8.66 | $7.8 | $8.9 | $7.75 | 886,678 | 04-05-2024 |
$8.68 | $8.79 | $8.68 | $8.94 | $8.59 | 444,558 | 04-04-2024 |
$8.7 | $8.78 | $8.7 | $9.03 | $8.39 | 799,759 | 04-03-2024 |
$8.87 | $8.86 | $8.87 | $8.99 | $8.7 | 407,834 | 04-02-2024 |
$8.97 | $9 | $8.97 | $9.07 | $8.54 | 484,275 | 04-01-2024 |
$9.04 | $8.91 | $9.04 | $9.24 | $8.825 | 869,000 | 03-29-2024 |
$9.04 | $8.91 | $9.04 | $9.24 | $8.825 | 869,000 | 03-28-2024 |
$8.85 | $8.86 | $8.85 | $9.0799 | $8.56 | 427,206 | 03-27-2024 |
$8.79 | $9.34 | $8.79 | $9.41 | $8.49 | 583,012 | 03-26-2024 |
$8.93 | $8.81 | $8.93 | $8.98 | $8.785 | 297,653 | 03-25-2024 |
$8.81 | $9.05 | $8.81 | $9.08 | $8.64 | 257,522 | 03-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Marinus Pharmaceuticals Inc. Company Name:
MRNS Stock Symbol:
NASDAQ Market:
Marinus Pharmaceuticals Inc. Website:
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Monday, in an interim analysis of Marinus Pharmaceuticals Inc’s (NASDAQ:MRNS) phase 3 RAISE trial, evaluating intravenous (IV) gana...
2024-04-16 08:15:04 ET Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for MRNS on April 16, 2024 06:31AM ET. The previous analyst recommendation was Overweight. MRNS was trading at $1.3 at issue of the analyst recommendation. The overall analyst consensus : H...